PER
Click for more information
2.44% 8.0¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-1073

  1. Fr3sno
    811 Posts.
    lightbulb Created with Sketch. 256
    clock Created with Sketch.
    27/10/21
    06:54
    Post #: 57097072
    You know what I just discovered and am now finding quite interesting in regards to Credit Suisse being a large buyer over the last month. (400k total).

    “Credit Suisse Securities (USA) LLC are acting as joint book-running managers for the offering.”

    That extract is from the Sarepta website in regards to the $500 million they are raising.. Hmm follow the $.
    ANP Price at posting: 31.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 35  Upvote
    lightbulb Created with Sketch. 7  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
STX Award of 85 MW capacity pushes Strike's Erregulla power station project closer to FID
right-arrow Created with Sketch.
NEWS Unchanged wage growth in June quarter, but public sector leaps ahead
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.002(2.44%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $58.49K 703.3K

Buyers (Bids)

No. Vol. Price($)
2 127624 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 25545 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.